Keven Ferreira da Ponte1,2, David Hassanein Berro1,2, Solène Collet1, Jean-Marc Constans1,3, Evelyne Emery2,4, Samuel Valable1, Jean-Sébastien Guillamo5,6,7. 1. Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, Caen, France. 2. Department of Neurosurgery, University Hospital of Caen, Caen, France. 3. Department of Neuroradiology, University Hospital of Caen, Caen, France. 4. Normandie University, UNICAEN, INSERM, Inserm UMR-S U919, Caen, France. 5. Normandie University, UNICAEN, CEA, CNRS, ISTCT/CERVOxy Group, Caen, France jeansebastien.GUILLAMO@chu-nimes.fr. 6. Department of Neurology, University Hospital of Caen, Caen, France; and. 7. Department of Neurology, University Hospital of Nimes, Nimes, France.
Abstract
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. This aggressiveness is in part attributed to the closely interrelated phenomena tumor hypoxia and angiogenesis, although few in vivo data exist in human brain tumors. This work aimed to study hypoxia and angiogenesis, in vivo and in situ, in patients admitted with GBM using multimodal imaging. Methods: Twenty-three GBM patients were assessed by 18F-fluoromisonidazole (18F-FMISO) PET and conventional and perfusion MRI before surgery. The level and location of hypoxia (18F-FMISO uptake, evaluated by tumor-to-blood [T/B] ratio), vascularization (cerebral blood volume [CBV]), and vascular permeability (contrast enhancement after gadolinium injection) were analyzed. The spatial relationship between tumor hypoxia and angiogenesis was assessed by an overlap analysis of the volume of 18F-FMISO uptake and the volumes of the high CBV regions and the contrast-enhancement regions. Results: A significant correlation was found between hypoxia and hypervascularization, especially for their maximum values (volume of maximal tumor hypoxia vs. relative CBV: r = 0.61, P = 0.002) and their volumes (hypoxia vs. hypervascularization: r = 0.91, P < 0.001). A large proportion of the high CBVs collocated with hypoxia (81.3%) and with contrast enhancement (46.5%). Conclusion: These results support the hypothesis of a tight association between hypoxia and angiogenesis. Our results suggest that there is insufficient tumor oxygenation in human GBM, despite increased tumor vascularization.
Glioblastoma multiforme (GBM) is the most common and aggressive primary brain tumor. This aggressiveness is in part attributed to the closely interrelated phenomena tumor hypoxia and angiogenesis, although few in vivo data exist in humanbrain tumors. This work aimed to study hypoxia and angiogenesis, in vivo and in situ, in patients admitted with GBM using multimodal imaging. Methods: Twenty-three GBM patients were assessed by 18F-fluoromisonidazole (18F-FMISO) PET and conventional and perfusion MRI before surgery. The level and location of hypoxia (18F-FMISO uptake, evaluated by tumor-to-blood [T/B] ratio), vascularization (cerebral blood volume [CBV]), and vascular permeability (contrast enhancement after gadolinium injection) were analyzed. The spatial relationship between tumor hypoxia and angiogenesis was assessed by an overlap analysis of the volume of 18F-FMISO uptake and the volumes of the high CBV regions and the contrast-enhancement regions. Results: A significant correlation was found between hypoxia and hypervascularization, especially for their maximum values (volume of maximal tumor hypoxia vs. relative CBV: r = 0.61, P = 0.002) and their volumes (hypoxia vs. hypervascularization: r = 0.91, P < 0.001). A large proportion of the high CBVs collocated with hypoxia (81.3%) and with contrast enhancement (46.5%). Conclusion: These results support the hypothesis of a tight association between hypoxia and angiogenesis. Our results suggest that there is insufficient tumor oxygenation in human GBM, despite increased tumor vascularization.
Authors: Robert J Harris; Jingwen Yao; Ararat Chakhoyan; Catalina Raymond; Kevin Leu; Linda M Liau; Phioanh L Nghiemphu; Albert Lai; Noriko Salamon; Whitney B Pope; Timothy F Cloughesy; Benjamin M Ellingson Journal: Magn Reson Med Date: 2018-04-06 Impact factor: 4.668
Authors: Y-L Wang; J Yao; A Chakhoyan; C Raymond; N Salamon; L M Liau; P L Nghiemphu; A Lai; W B Pope; N Nguyen; M Ji; T F Cloughesy; B M Ellingson Journal: AJNR Am J Neuroradiol Date: 2019-05-16 Impact factor: 3.825
Authors: Seth T Gammon; Federica Pisaneschi; Madhavi L Bandi; Melinda G Smith; Yuting Sun; Yi Rao; Florian Muller; Franklin Wong; John De Groot; Jeffrey Ackroyd; Osama Mawlawi; Michael A Davies; Y N Vashisht Gopal; M Emilia Di Francesco; Joseph R Marszalek; Mark Dewhirst; David Piwnica-Worms Journal: Cells Date: 2019-11-21 Impact factor: 6.600
Authors: Elizabeth R Gerstner; Kyrre E Emblem; Yi-Fen Yen; Jorg Dietrich; Justin T Jordan; Ciprian Catana; Kevin Lou Wenchin; Jacob M Hooker; Dan G Duda; Bruce R Rosen; Jayashree Kalpathy-Cramer; Rakesh K Jain; Tracy T Batchelor Journal: Neurooncol Adv Date: 2020-11-17